Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126100531 | 12610053 | 1 | I | 20160721 | 20160801 | 20160801 | PER | US-009507513-1607USA012274 | MERCK | 93.00 | YR | F | Y | 0.00000 | 20160801 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126100531 | 12610053 | 1 | PS | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG TABLET BY MOUTH AT BEDTIME | 20829 | 10 | MG | TABLET | QD | ||||||
| 126100531 | 12610053 | 2 | SS | REMERON | MIRTAZAPINE | 1 | Oral | 15 MG TABLET BY MOUTH AT BEDTIME | 0 | 15 | MG | TABLET | QD | ||||||
| 126100531 | 12610053 | 3 | SS | REMERON | MIRTAZAPINE | 1 | Oral | 7.5 MG AT BEDTIME | 0 | 7.5 | MG | TABLET | QD | ||||||
| 126100531 | 12610053 | 4 | SS | PEPCID RPD | FAMOTIDINE | 1 | Oral | 20 MG, BID | 0 | 20 | MG | WAFER | BID | ||||||
| 126100531 | 12610053 | 5 | SS | PEPCID RPD | FAMOTIDINE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | WAFER | QD | ||||||
| 126100531 | 12610053 | 6 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | TWO 500MG TABLETS BY MOUTH THREE TIMES DAILY | 0 | 2 | DF | TABLET | TID | ||||||
| 126100531 | 12610053 | 7 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0.25 MG, BID | 0 | .25 | MG | TABLET | BID | ||||||
| 126100531 | 12610053 | 8 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | AS NEEDED EVERY 8 HOURS | 0 | TABLET | Q8H | ||||||||
| 126100531 | 12610053 | 9 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG TABLET BY MOUTH DAILY | 0 | 10 | MG | TABLET | QD | ||||||
| 126100531 | 12610053 | 10 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG TABLET BY MOUTH AT BEDTIME | 0 | 75 | MG | TABLET | QD | ||||||
| 126100531 | 12610053 | 11 | C | DONEPEZIL. | DONEPEZIL | 1 | Oral | 10 MG TABLET BY MOUTH AT BEDTIME | 0 | 10 | MG | TABLET | QD | ||||||
| 126100531 | 12610053 | 12 | C | fluticasone propionate (+) salmeterol xinafoate | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | ORAL INHALATION EVERY 12 HOURS | 0 | Q12H | |||||||||
| 126100531 | 12610053 | 13 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 125 MCG TABLET BY MOUTH DALLY | 0 | TABLET | QD | ||||||||
| 126100531 | 12610053 | 14 | C | MEMANTINE. | MEMANTINE | 1 | Oral | 10 MG TABLET BY MOUTH TWICE DALLY | 0 | TABLET | BID | ||||||||
| 126100531 | 12610053 | 15 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 50 MG TABLET BY MOUTH DALLY | 0 | TABLET | QD | ||||||||
| 126100531 | 12610053 | 16 | C | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | Oral | 6.25 MG TABLET BY MOUTH AT BEDTIME | 0 | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126100531 | 12610053 | 1 | Asthma |
| 126100531 | 12610053 | 2 | Depression |
| 126100531 | 12610053 | 3 | Decreased appetite |
| 126100531 | 12610053 | 4 | Gastrooesophageal reflux disease |
| 126100531 | 12610053 | 6 | Fracture pain |
| 126100531 | 12610053 | 7 | Agitation |
| 126100531 | 12610053 | 9 | Hypertension |
| 126100531 | 12610053 | 10 | Coronary artery disease |
| 126100531 | 12610053 | 11 | Dementia |
| 126100531 | 12610053 | 12 | Asthma |
| 126100531 | 12610053 | 13 | Hypothyroidism |
| 126100531 | 12610053 | 14 | Dementia |
| 126100531 | 12610053 | 15 | Hypertension |
| 126100531 | 12610053 | 16 | Insomnia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126100531 | 12610053 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |